Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (191-200 of 462) with videos related to

Pageof 47
Sort By:
Inflammatory Bowel Diseases|December 16, 2020
Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD RegistryManasi Agrawal, Erica J Brenner, Xian Zhang, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2022
Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort studySandra Bohn Thomsen, Ryan C Ungaro, Kristine H Allin, et al.
Gut|November 17, 2017
Adherent-invasive <i>Escherichia coli</i> in inflammatory bowel diseaseCarolina Palmela, Caroline Chevarin, Zhilu Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2021
ReplyEmily C L Wong, Parambir S Dulai, Neil K Sengupta, et al.
The Lancet. Gastroenterology & Hepatology|February 15, 2025
Inflammatory bowel disease in south Asia: a scoping reviewShabari Shenoy, Anuraag Jena, Carrie Levinson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 23, 2020
Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn's Disease: A Systematic Review and Pooled Meta-analysisDavid M Faleck, Eugenia Shmidt, Ruiqi Huang, et al.
Gut|November 14, 2018
Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohortsRyan C Ungaro, Berkeley N Limketkai, Camilla Bjørn Jensen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 27, 2019
Home vs Hospital Infusion of Biologic Agents for Patients With Inflammatory Bowel DiseasesMarc Fenster, Ryan C Ungaro, Robert Hirten, et al.
The American Journal of Gastroenterology|August 8, 2020
Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC TrialNeeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.
Journal of Clinical Gastroenterology|October 13, 2022
Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's DiseaseNeeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.
Pageof 47

Showing results (191-200 of 462) with videos related to

Sort By:
Pageof 47
Inflammatory Bowel Diseases|December 16, 2020
Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD RegistryManasi Agrawal, Erica J Brenner, Xian Zhang, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2022
Impact of thiopurine discontinuation at anti-tumour necrosis factor initiation in inflammatory bowel disease treatment: a nationwide Danish cohort studySandra Bohn Thomsen, Ryan C Ungaro, Kristine H Allin, et al.
Gut|November 17, 2017
Adherent-invasive <i>Escherichia coli</i> in inflammatory bowel diseaseCarolina Palmela, Caroline Chevarin, Zhilu Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 31, 2021
ReplyEmily C L Wong, Parambir S Dulai, Neil K Sengupta, et al.
The Lancet. Gastroenterology & Hepatology|February 15, 2025
Inflammatory bowel disease in south Asia: a scoping reviewShabari Shenoy, Anuraag Jena, Carrie Levinson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 23, 2020
Effect of Concomitant Therapy With Steroids and Tumor Necrosis Factor Antagonists for Induction of Remission in Patients With Crohn's Disease: A Systematic Review and Pooled Meta-analysisDavid M Faleck, Eugenia Shmidt, Ruiqi Huang, et al.
Gut|November 14, 2018
Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohortsRyan C Ungaro, Berkeley N Limketkai, Camilla Bjørn Jensen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 27, 2019
Home vs Hospital Infusion of Biologic Agents for Patients With Inflammatory Bowel DiseasesMarc Fenster, Ryan C Ungaro, Robert Hirten, et al.
The American Journal of Gastroenterology|August 8, 2020
Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC TrialNeeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.
Journal of Clinical Gastroenterology|October 13, 2022
Baseline Patient-reported Symptoms Less Predictive Than MM-SES-CD for Endoscopic Remission in Crohn's DiseaseNeeraj Narula, Emily C L Wong, Achuthan Aruljothy, et al.
Pageof 47